Covid 19

COVID-19 Treatment: Investigational Drugs and Other Therapies

Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; formerly called 2019-nCoV), which was first identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China.  It was initially reported to the World Health Organization (WHO) on December 31, […]

pharma

Pharma Solutions Will Establish a Collaboration and Business Partnership with MSN Group

On April Pharma Solutions started negotiations with MSN on the way forward for mutual collaboration and business partnership MSN Group is the fastest growing research-based pharmaceutical company based out of India. Founded in 2003 with a mission to make health care affordable, this Hyderabad-based venture has nine Active Pharmaceutical Ingredients (API) and five finished dosage […]

UAE approval for MyLan

We have the pleasure to announce the UAE Ministry of Health & Prevention (MoHAP) approval for; Ricovir-EM® (tenofovir/emtricitabine) 300mg/200mg film-coated Tablets, 30s HDPE bottle Ricovir-EM® is a double combination therapy for the treatment of HIV-1 infected adults. Mylan is committed to manufacturing low-cost, high-quality generics thus contributing to affordable healthcare. Mylan is also involved in […]

Aurobindo

We are pleased to announce Pharma Solutions exclusive partnership with Aurobindo Pharma, one of the largest Pharmaceutical companies in India with a global footprint. Pharma Solutions will exclusively market & distribute Aurobindo Oncology products in key treatment centers in the UAE.

Helsinn Healthcare SA

Retroactive, March 20th, 2018, Helsinn acquired worldwide rights to Valchlor/Ledaga, an alkalyting agent for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) from Actelion Pharmaceuticals Ltd. More details in this link.